ABSTRACT
with FTLD-TDP according to pathologic subtype and examined the associated antemortem clinical, neuropsychological, and neuroimaging features. We hypothesized that 1) type 1 would be associated with semantic dementia, including patients with both left-and right-predominant temporal polar disease, and would show corresponding asymmetric atrophy within a temporal pole network for semantic and emotional meaning, 2) type 2 would be predominantly associated with behavioral variant FTD (bvFTD), with or without motor neuron disease (MND), and would show frontoinsular and medial frontal atrophy, and 3) type 3 would include most patients with PNFA or CBS and feature more dorsal frontoparietal and dorsal insular atrophy.
METHODS Subjects. Subjects were recruited from a consecutive series of patients attending the Memory and Aging Center at the University of California, San Francisco (UCSF) with a primary neuropathologic diagnosis of FTLD-TDP and an antemortem volumetric MRI brain scan performed on a 1.5-T magnetic resonance scanner. Because comorbid Alzheimer disease-related and Lewy body pathologies are common in older subjects, the presence of one or more of these comorbidities did not constitute an exclusion criterion. A control group of 50 age-and gender-matched cognitively normal subjects was also included: 28 male subjects, mean age at scan of 61.4 years (SD ϭ 7.8).
Standard protocol approvals, registrations, and patient consents. Ethical approval for the study was obtained from UCSF Committee on Human Research. Written research consent was obtained from all patients prior to study participation.
Clinical and neuropsychological assessment. All patients underwent a standard clinical assessment including Mini-Mental State Examination (MMSE, 11) and the Clinical Dementia Rating (CDR, 12). Neuropsychometry was also performed including assessment of naming (Abbreviated Boston Naming Test, 13), verbal memory (California Verbal Learning Test-short form, 14), visuospatial skills and visual memory (modified Rey Figure, Brain imaging. Structural MRI was performed with a 1.5-T Magneton VISION system (Siemens Inc., Iselin, NJ). A volumetric magnetization-prepared rapid gradient echo MRI (repetition time, 10 msec; echo time, 4 msec; inversion time, 300 msec) was used to obtain a T1-weighted image of the entire brain (15°f lip angle, coronal orientation perpendicular to the double spin echo sequence, 1.0 ϫ 1.0 mm 2 in-plane resolution of 1.5-mm slab thickness). Initially, cortical and subcortical volumes were generated using the Freesurfer analysis suite (http://surfer.nmr.mgh.harvard.edu/). This allowed a left/right asymmetry ratio to be calculated by dividing the total left hemisphere volumes by the right hemisphere volumes to provide a measure of how asymmetric the atrophy was in each patient. Voxel-based morphometry (VBM) was performed using SPM5 software (http://www.fil.ion.ucl.ac.uk/spm) and the DARTEL toolbox with default settings for all parameters. 18 Voxel gray matter intensity, V, was modeled as a function of group, and subject age, gender, and total intracranial volume (calculated within SPM5) were included as nuisance covariates. Maps showing significant differences between the groups were generated, correcting for multiple comparisons by thresholding the images of t statistics to control the false discovery rate (FDR) at a 0.001 significance level. Statistical parametric maps were displayed as overlays on a study-specific template, created by warping all native space whole-brain images to the final DARTEL template and calculating the average of the warped brain images.
Neuropathologic assessment. All patients underwent a comprehensive neuropathologic assessment as previously described. 19, 20 Briefly, fixation protocols varied depending on the site and date of autopsy. Although all patients were clinically evaluated at UCSF, autopsies were divided between UCSF and the University of Pennsylvania. For all brains autopsied at the University of Pennsylvania and some autopsied at UCSF, whole hemispheres were immersion fixed in 10% neutral buffered formalin for at least 1 week. Additional brains autopsied at UCSF were freshly cut into 8-to 10-mm-thick whole-brain coronal slabs. These slabs were alternately fixed, in freshly made 4% paraformaldehyde for 72 hours, or rapidly frozen. Tissue blocks covering neocortical, limbic, subcortical, and brainstem regions were dissected following consensus guidelines for the standardized assessment of dementia neuropathology, 21 and basic and immunohistochemical stains were applied. Immunohistochemistry was performed using antibodies to ubiquitin (antirabbit, 1:1,000, DAKO North America, Carpinteria, CA), TDP43 (antirabbit, 1:2,000, Proteintech Group, Chicago, IL), hyperphosphorylated tau (CP-13 antibody, courtesy of P. Further pathologic subtyping of the patients with FTLD-TDP was performed. Two closely related nomenclatures have been put forward for FTLD-TDP subtyping 4, 5 : type 1 Sampathu (type 2 Mackenzie) is associated with long, TDP-43 immunoreactive, dystrophic neurites but few neuronal cytoplasmic inclusions; type 2 Sampathu (type 3 Mackenzie) is associated with predominantly granular or stippled neuronal cytoplasmic inclusions in superficial and deep layers; and type 3 Sampathu (type 1 Mackenzie) is associated with crescentic or compact neuronal cytoplasmic inclusions, abundant short angulated neuropil threads, and, more variably, neuronal intranuclear inclusions. 6, 7 Patients with null mutations in progranulin who have come to autopsy have shown Sampathu type 3 FTLD-TDP. 22 A fourth rare subtype associated with mutations in the valosin-containing protein gene has also been described. 6 For clarity, the Sampathu scheme is applied throughout the remainder of the article.
RESULTS Twenty-eight patients met entry criteria and were included in the study (18 men, 10 women) with a mean age at scan of 62.4 years (SD ϭ 7.9). Nine patients had type 1 pathology, 5 had type 2, 10 had type 3 (including 2 with known progranulin mutations), and 4 had FTLD-TDP pathology that proved too sparse to be subtyped (table 1). In the unclassifiable group, TDP-43 pathology took the form of rare compact, granular, crescentic, or skeinlike neuronal cytoplasmic inclusions, glial cytoplasmic inclusions, or short dystrophic neurites in superficial or deep layers, with some variation between cases. Anterior cingulate cortex and dentate gyrus granule cells were consistently sampled and showed scarce TDP-43 pathology in all unclassifiable patients, although other frontal and temporal regions showed some pathology in selected patients.
Clinical diagnosis varied between the groups, with semantic dementia seen only in FTLD-TDP type 1, with no other clinical diagnosis made in patients with this pathology. Although patients with both left-and right-predominant bitemporal atrophy all had semantic impairment characteristic of semantic dementia, behavioral symptoms were more con- Abbreviations: AD ϭ Alzheimer disease; bvFTD ϭ behavioral variant frontotemporal dementia; CAA ϭ cerebral amyloid angiopathy; CBS ϭ corticobasal syndrome; FTD ϭ frontotemporal dementia; FTLD-TDP ϭ frontotemporal lobar degeneration with TDP-43 immunoreactive inclusions; HS ϭ hippocampal sclerosis; MND ϭ motor neuron disease; PNFA ϭ progressive nonfluent aphasia; SEMD ϭ semantic dementia; TDP-43 ϭ TAR DNA-binding protein of 43 kDa.
spicuous in the right-predominant patients and were often the first manifestations. These patients were clinically classified as semantic dementia due to the profound semantic impairment at presentation, although they may have been classified as bvFTD at some centers if seen earlier in the disease course. Progressive nonfluent aphasia (PNFA) and corticobasal syndrome (CBS) were only seen in type 3 pathology, although both bvFTD and FTD-MND were seen in type 2 and type 3. All 4 patients in whom the FTLD-TDP could not be subtyped had clinical FTD-MND (table 1) . Age at onset and disease duration overlapped between the subgroups although there was longer duration in the type 1 subtype compared to type 3 ( p ϭ 0.02) and a trend toward longer duration compared to type 2 (tables 1 and 2). All groups contained patients with asymmetric atrophy although type 1 was the most asymmetric (4 patients memory tests was worse in the left-sided group compared to right, whereas performance on visual memory tests was worse in the right-sided group (table e-1). Executive function was worst in the type 2 patients with poorer performance on the Trail Making Test than type 1 ( p ϭ 0.04) and a trend to worse performance than type 3 ( p ϭ 0.09). VBM analysis was performed in both the total TDP groups and also in subgroups defined by left-or right-predominant atrophy. Type 1 was associated with atrophy in the temporal lobes (especially in polar and anterior regions), the amygdalae, hippocampi, orbitofrontal lobes, and insulae (figure 1). Subgrouping the patients by side of worst atrophy highlighted the asymmetric nature of the illness, which can be either left-or right-predominant with a mirror-image pattern seen in the 2 groups (figure 1). Significant atrophy in type 2 was identified in medial and polar temporal lobes, especially on the left, as well as anterior cingulate, anterior insulae, medial prefrontal, and orbitofrontal cortices. Although the pattern was relatively symmetric outside of the temporal lobe, one patient in this group showed leftpredominant atrophy (table 1) , which most likely drove the asymmetric temporal atrophy effect shown in figure 2. Splitting the type 2 group by side of worst atrophy left only small groups for analysis, and only the leftsided group showed significantly atrophied regions, Figure 1 Voxel-based morphometry analysis on gray matter regions in the type 1 group relative to healthy controls (A) and in the type 1 subgroups with left-and right-sided predominant atrophy (B)
Statistical parametric maps have been thresholded at p Ͻ 0.001 after false discovery rate correction over the whole brain volume and rendered on a study-specific average group T1-weighted MRI template image in DARTEL space. The color bar (left) indicates the t score. The left hemisphere is shown on the left of each figure.
Figure 2
Voxel-based morphometry analysis on gray matter regions in the type 2 group relative to healthy controls Statistical parametric maps have been thresholded at p Ͻ 0.001 after false discovery rate correction over the whole brain volume and rendered on a study-specific average group T1-weighted MRI template image in DARTEL space. The color bar (left) indicates the t score. The left hemisphere is shown on the left of each figure.
mostly asymmetric (left greater than right) medial temporal lobe. In type 3, the atrophy showed a more dorsal pattern, including the inferior, middle, and superior frontal gyri, anterior, medial, and posterior temporal regions, amygdalae, insulae, anterior cingulate, orbitofrontal cortex, inferior parietal lobes, striatum, and thalamus ( figure 3 ). Similar mirror-image patterns were seen in the subgroups with right-and left-sided predominant atrophy, although the extent of atrophy in each group varied, most likely due to differences in sample size. The unspecified TDP group did not show areas of significant atrophy at the predetermined statistical significance threshold.
DISCUSSION Consistent with previous studies, [5] [6] [7] [8] [9] this study shows that different FTD clinical syndromes and patterns of neuropsychological impairment are seen in each FTLD-TDP subtype. Following from these observations, this study links each TDP-43 subtype to distinct cerebral atrophy patterns. Type 1 FTLD-TDP is associated with semantic dementia and with either left or right-predominant anterior temporal lobe atrophy. Type 2 is associated with bvFTD or FTD-MND and a more symmetric pattern involving the anteromedial temporal and orbitomedial frontal lobes and anterior insulae. Type 3 is associated with PNFA and corticobasal syndrome, as well as with bvFTD and FTD-MND. Accordingly, we identified a more dorsal pattern of asymmetric atrophy affecting the frontal, temporal, and insular lobes as well as the anterior cingulate and parietal areas. The unclassifiable patients all presented with FTD-MND, but no significant areas of atrophy were detected. The present clinical and anatomic associations argue that TDP-43 subtyping provides a biologically significant framework for understanding the FTLD-TDP spectrum. Previous pathologic FTLD series have investigated the clinical features associated with TDP-43 pathology although without subtype-specific imaging analysis. 2, 9, [23] [24] [25] [26] [27] [28] [29] Findings in this study consistent with previous work are the association of semantic dementia with type 1 2 and the association of PNFA and CBS with type 3, including patients with progranulin mutations.
10,24 FTD-MND has been associated most closely with Type 2 pathology 2 but also in some series with type 3 23, 25 (as in this study). The percentage of cases with FTD-MND and type 3 FTLD-TDP varies widely between series, with some reporting no cases 29 and one reporting MND in almost half of the patients with type 3 pathology. 25 A recent study suggested, based on a principle component analysis of reduced neuropathologic data, that TDP-43 pathology forms a continuum rather than distinct subtypes. 30 Our findings, in contrast, provide novel neuroimaging evidence to support TDP-43 subtyping as a biologically meaningful and constructive framework for understanding FTLD-TDP. Four patients who could not be categorized according to current schemes had MND and Figure 3 Voxel-based morphometry analysis on gray matter regions in the type 3 group relative to healthy controls (A) and in the type 3 subgroups with right-and left-sided predominant atrophy (B)
Statistical parametric maps have been thresholded at p Ͻ 0.001 after false discovery rate correction over the whole brain volume and rendered on a study-specific average group T1-weighted MRI template image in DARTEL space. The color bar (left) indicates the t score. The left hemisphere is shown on the left of each figure. died with TDP-43 pathology too sparse to classify. Consistent with a short disease duration and better performance on neuropsychological testing, these patients showed no significant atrophy in the VBM analysis, and the brains of these patients showed little cerebral gross atrophy at postmortem. Finally, this study demonstrates the atrophy pattern seen in semantic dementia due to a single underlying pathology. Previous studies suggest that type 1 FTLD-TDP is by far the most common pathologic substrate for this syndrome, 31 but some patients with FTLD-tau or Alzheimer disease also present with semantic dementia and may show a different anatomic pattern. 32 This heterogeneity could have altered prior imaging findings based on living patients with mixed pathologic substrates. Here, patients with type 1 FTLD-TDP and semantic dementia featuring leftand right-predominant degeneration showed nearly mirror-image atrophy patterns, supporting the notion that these 2 clinical syndromes reflect the same underlying disorder.
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